Your browser doesn't support javascript.
loading
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
Friebel, Julian; Weithauser, Alice; Witkowski, Marco; Rauch, Bernhard H; Savvatis, Konstantinos; Dörner, Andrea; Tabaraie, Termeh; Kasner, Mario; Moos, Verena; Bösel, Diana; Gotthardt, Michael; Radke, Michael H; Wegner, Max; Bobbert, Peter; Lassner, Dirk; Tschöpe, Carsten; Schutheiss, Heinz-Peter; Felix, Stephan B; Landmesser, Ulf; Rauch, Ursula.
  • Friebel J; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Weithauser A; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Witkowski M; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Rauch BH; Institute of Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Felix-Hausdorff-Str. 3, Greifswald, Germany.
  • Savvatis K; German Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Ferdinand-Sauerbruch-Str., Greifswald, Germany.
  • Dörner A; Inherited Cardiovascular Diseases Unit, Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London, UK.
  • Tabaraie T; William Harvey Research Institute, Queen Mary University London, Charterhouse Square, London, UK.
  • Kasner M; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Moos V; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Bösel D; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Gotthardt M; Medical Department I, Gastroenterology, Infectious Diseases and Rheumatology, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Radke MH; Medical Department I, Gastroenterology, Infectious Diseases and Rheumatology, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Wegner M; Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Robert-Rössle-Str. 10, Berlin, Germany.
  • Bobbert P; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Oudenarder Straße 16, Berlin, Germany.
  • Lassner D; Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Robert-Rössle-Str. 10, Berlin, Germany.
  • Tschöpe C; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Oudenarder Straße 16, Berlin, Germany.
  • Schutheiss HP; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
  • Felix SB; Department of Internal Medicine and Angiology, Hubertus Hospital, Berlin, Spanische Allee 10-14, Berlin, Germany.
  • Landmesser U; Institute for Cardiac Diagnostics and Therapy (IKDT), Moltkestr. 31, Berlin, Germany.
  • Rauch U; Department of Cardiology, Charité Center 11, Charité-University Medicine Berlin, Hindenburgdamm 30, Berlin, Germany.
Eur Heart J ; 40(40): 3318-3332, 2019 10 21.
Article en En | MEDLINE | ID: mdl-31004144

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis / Receptor PAR-2 / Cardiomiopatías / Miocardio Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis / Receptor PAR-2 / Cardiomiopatías / Miocardio Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article